Managing Medicines in Special Schools
... b. The Special school Nursing Service Lead will be responsible for ensuring the guidance is safe and reflects best practice. c. WHCT nursing staff (registered & non-registered) will be responsible for adhering to the guideline and raising any concern or issues that are experienced relating to it. d. ...
... b. The Special school Nursing Service Lead will be responsible for ensuring the guidance is safe and reflects best practice. c. WHCT nursing staff (registered & non-registered) will be responsible for adhering to the guideline and raising any concern or issues that are experienced relating to it. d. ...
UKMi FAQ 18 - NHS Evidence Search
... amlodipine than felodipine m/r. Similarly the peak-to-trough plasma concentration ratio was more favourable for amlodipine compared to felodipine m/r. It was not established whether these characteristics reflected ‘smoother and more consistent’ blood pressure control. A number of clinical studies ha ...
... amlodipine than felodipine m/r. Similarly the peak-to-trough plasma concentration ratio was more favourable for amlodipine compared to felodipine m/r. It was not established whether these characteristics reflected ‘smoother and more consistent’ blood pressure control. A number of clinical studies ha ...
Update of the Topical Treatment of Psoriasis
... In 7 double-blind randomized trials including more than 6000 patients, the application of the betamethasone/ calcipotriol formulation once or twice daily achieved a mean reduction in the Psoriasis Area and Severity Index (PASI) of between 65% and 74% at 4 weeks (evidence level I).20-27 These results ...
... In 7 double-blind randomized trials including more than 6000 patients, the application of the betamethasone/ calcipotriol formulation once or twice daily achieved a mean reduction in the Psoriasis Area and Severity Index (PASI) of between 65% and 74% at 4 weeks (evidence level I).20-27 These results ...
DOTS strategy
... Strengthen basic TB control, to prevent M/XDR-TB Scale-up programmatic management and care of MDR-TB and XDR-TB Strengthen laboratory services for adequate and timely diagnosis of MDR-TB and XDR-TB Ensure availability of quality drugs and their rational use Expand MDR-TB and XDR-TB surveillance Intr ...
... Strengthen basic TB control, to prevent M/XDR-TB Scale-up programmatic management and care of MDR-TB and XDR-TB Strengthen laboratory services for adequate and timely diagnosis of MDR-TB and XDR-TB Ensure availability of quality drugs and their rational use Expand MDR-TB and XDR-TB surveillance Intr ...
- Worcestershire Acute Hospitals NHS Trust
... This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the circumstances of the individual patient in consultation with the patient and /or carer. Health care professionals must be prepared to justify any deviation from this gu ...
... This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the circumstances of the individual patient in consultation with the patient and /or carer. Health care professionals must be prepared to justify any deviation from this gu ...
Enhancing adherence in clinical research
... individuals may vary in terms of their adherence to specific components of medical regimens. This is evidenced by low correlations of adherence estimates among specific aspects of diabetes regimens [25]. The causes of non-adherence are complex, multivaried, and probably vary among people. The Boston ...
... individuals may vary in terms of their adherence to specific components of medical regimens. This is evidenced by low correlations of adherence estimates among specific aspects of diabetes regimens [25]. The causes of non-adherence are complex, multivaried, and probably vary among people. The Boston ...
Design of Comparative Experiments
... for the treatment that you are trying to prove is best) I accidental bias (for example, using the first rats that the animal handler takes out of the cage for one treatment and the last rats for the other) I cheating by the experimenter: I ...
... for the treatment that you are trying to prove is best) I accidental bias (for example, using the first rats that the animal handler takes out of the cage for one treatment and the last rats for the other) I cheating by the experimenter: I ...
Treatment of Tuberculosis Disease
... Definitions of abbreviations: EMB = ethambutol; FDA = Food and Drug Administration; INH = isoniazid; PZA = pyrazinamide; RFB = rifabutin; RIF = rifampin; RPT = rifapentine. * Dose per weight is based on ideal body weight. Children weighing more than 40 kg should be dosed as adults. † For the purpose ...
... Definitions of abbreviations: EMB = ethambutol; FDA = Food and Drug Administration; INH = isoniazid; PZA = pyrazinamide; RFB = rifabutin; RIF = rifampin; RPT = rifapentine. * Dose per weight is based on ideal body weight. Children weighing more than 40 kg should be dosed as adults. † For the purpose ...
4: Central nervous system - Gateshead Health NHS Foundation Trust
... - Chlorpromazine tablets 10mg, 25mg, 50mg, 100mg; syrup 25mg/5mL, 100mg/5mL: initially 25mg 3 times daily (or 75mg at night) adjusted to response; usual maintenance dose 75-300mg daily (up to 1g daily may be required in psychoses). - Chlorpromazine injection 25mg/mL: by deep intramuscular injection ...
... - Chlorpromazine tablets 10mg, 25mg, 50mg, 100mg; syrup 25mg/5mL, 100mg/5mL: initially 25mg 3 times daily (or 75mg at night) adjusted to response; usual maintenance dose 75-300mg daily (up to 1g daily may be required in psychoses). - Chlorpromazine injection 25mg/mL: by deep intramuscular injection ...
Managing Hypertension
... respectively. Those clinical guidelines were distributed throughout the Primary Health Care system of the entire English speaking Caribbean, targeting all primary care doctors, nurses, nurse practitioners and other health care personnel involved in the care of persons with diabetes and hypertension. ...
... respectively. Those clinical guidelines were distributed throughout the Primary Health Care system of the entire English speaking Caribbean, targeting all primary care doctors, nurses, nurse practitioners and other health care personnel involved in the care of persons with diabetes and hypertension. ...
Drug Regulation: History, Present and Future
... applications (NDA) and, for the first time, demanded that a new drug should be proven to be effective and safe. Of equal importance, the FDA was also given the authority to require compliance with current Good Manufacturing Practices (GMP), to officially register drug establishments and implement ot ...
... applications (NDA) and, for the first time, demanded that a new drug should be proven to be effective and safe. Of equal importance, the FDA was also given the authority to require compliance with current Good Manufacturing Practices (GMP), to officially register drug establishments and implement ot ...
GUÍA DEL MEDICAMENTO INCIVEK
... combination with peginterferon alfa and ribavirin, for the treatment of genotype 1 chronic hepatitis C (CHC) in adult patients with compensated liver disease, including cirrhosis, who are treatment-naïve or who have been previously treated with interferon-based treatment, including prior null respon ...
... combination with peginterferon alfa and ribavirin, for the treatment of genotype 1 chronic hepatitis C (CHC) in adult patients with compensated liver disease, including cirrhosis, who are treatment-naïve or who have been previously treated with interferon-based treatment, including prior null respon ...
(PSD) March 2016 PBAC Meeting
... Approximately 28 to 42 more patients suffered at least one neutropenia event. Approximately 3 to 9 more patients suffered at least one severe (grade 3/4/5) diarrhoea event. ...
... Approximately 28 to 42 more patients suffered at least one neutropenia event. Approximately 3 to 9 more patients suffered at least one severe (grade 3/4/5) diarrhoea event. ...
The effectiveness of buprenorphine in treating opioid
... poor lifestyle choices, accidents Hulse, English, Milne, & Holman (1999) ...
... poor lifestyle choices, accidents Hulse, English, Milne, & Holman (1999) ...
A Practical Approach to the Treatment of Low
... illnesses, and its underlying cause is generally benign. Fever may have a beneficial effect in terms of fighting infection [1], although its value in the recovery process is far from clear, since in vivo data are largely lacking. Fever can, however, be associated with distress and discomfort in chil ...
... illnesses, and its underlying cause is generally benign. Fever may have a beneficial effect in terms of fighting infection [1], although its value in the recovery process is far from clear, since in vivo data are largely lacking. Fever can, however, be associated with distress and discomfort in chil ...
Emerging Infectious Diseases- The Economic Impact of a Bioterrorist
... (3-5). Case-fatality rates were also assumed to vary by the day symptoms were first noted. The case-fatality rate was estimated as 85% for patients with symptoms on day 1; 80% for patients with symptoms on day 2; 70% for those with symptoms on day 3; 50% for those with symptoms on days 4, 5, and 6; ...
... (3-5). Case-fatality rates were also assumed to vary by the day symptoms were first noted. The case-fatality rate was estimated as 85% for patients with symptoms on day 1; 80% for patients with symptoms on day 2; 70% for those with symptoms on day 3; 50% for those with symptoms on days 4, 5, and 6; ...
A Comparison of Oral Azithromycin with Topical Oxytetracycline
... noted in our previous studies in Egypt. This group does not include three children whose family did not want them to participate in the study; another child was excluded because there was no record of the initial examination. In most cases, children were lost to follow-up at specific examinations be ...
... noted in our previous studies in Egypt. This group does not include three children whose family did not want them to participate in the study; another child was excluded because there was no record of the initial examination. In most cases, children were lost to follow-up at specific examinations be ...
Scarlet fever Have I got the right topic? All ages This CKS topic
... This CKS topic covers the management of scarlet fever in children and adults. This CKS topic does not cover the management of other infections with group A beta-haemolytic streptococcus (also known as Streptococcus pyogenes), or the management of complications of scarlet fever (for example rheumatic ...
... This CKS topic covers the management of scarlet fever in children and adults. This CKS topic does not cover the management of other infections with group A beta-haemolytic streptococcus (also known as Streptococcus pyogenes), or the management of complications of scarlet fever (for example rheumatic ...
MMIC PA Guidelines
... authorization will be given upon receipt of a Specialist Consult or after trial and failure of 2 formulary medications. Primary care providers, within the scope of their practice, who wish to provide psychotropic medications and medication adjustment and monitoring services may do so for members dia ...
... authorization will be given upon receipt of a Specialist Consult or after trial and failure of 2 formulary medications. Primary care providers, within the scope of their practice, who wish to provide psychotropic medications and medication adjustment and monitoring services may do so for members dia ...
(PSD) November 2016 PBAC Meeting - (Word 76KB)
... Four atypical LAI antipsychotics are currently listed on the PBS for the treatment of schizophrenia. Risperidone fortnightly LAI was recommended for listing on a costeffectiveness basis versus risperidone tablets in July 2004. Olanzapine one month LAI was recommended for listing in July 2009, based ...
... Four atypical LAI antipsychotics are currently listed on the PBS for the treatment of schizophrenia. Risperidone fortnightly LAI was recommended for listing on a costeffectiveness basis versus risperidone tablets in July 2004. Olanzapine one month LAI was recommended for listing in July 2009, based ...
Fixed combination of arthemether and lumefantrine
... The first application for the inclusion of artemether/lumefantrine in the WHO Model List of Essential Drugs was reviewed by the Expert Committee on Essential Drugs in 1999 (WHO, 2000a). The Committee considered that the combination had the potential to play an important role in the management of unc ...
... The first application for the inclusion of artemether/lumefantrine in the WHO Model List of Essential Drugs was reviewed by the Expert Committee on Essential Drugs in 1999 (WHO, 2000a). The Committee considered that the combination had the potential to play an important role in the management of unc ...
4: Central nervous system - Gateshead Health NHS Foundation Trust
... - Chlorpromazine tablets 10mg, 25mg, 50mg, 100mg; syrup 25mg/5mL, 100mg/5mL: initially 25mg 3 times daily (or 75mg at night) adjusted to response; usual maintenance dose 75-300mg daily (up to 1g daily may be required in psychoses). - Chlorpromazine injection 25mg/mL: by deep intramuscular injection ...
... - Chlorpromazine tablets 10mg, 25mg, 50mg, 100mg; syrup 25mg/5mL, 100mg/5mL: initially 25mg 3 times daily (or 75mg at night) adjusted to response; usual maintenance dose 75-300mg daily (up to 1g daily may be required in psychoses). - Chlorpromazine injection 25mg/mL: by deep intramuscular injection ...
Acamprosate - NHS Trafford CCG
... patients who remain under the care of the SMS – or on an ad hoc basis for other patients. The National Enhanced Service (alcohol) clinics can also be used to provide assessment and guidance regarding clinical management. The prescribing clinician, however, will hold continuing responsibility for the ...
... patients who remain under the care of the SMS – or on an ad hoc basis for other patients. The National Enhanced Service (alcohol) clinics can also be used to provide assessment and guidance regarding clinical management. The prescribing clinician, however, will hold continuing responsibility for the ...
Melatonin - Wolverhampton Formulary
... immediate release tablet or (unlicensed) oral solution and as such provides a viable alternative to either of these options. However, to the extent that Circadin® is a licensed product, its use outside of licence (in so far as the tablet is broken or crushed) is considered preferable to an unlicense ...
... immediate release tablet or (unlicensed) oral solution and as such provides a viable alternative to either of these options. However, to the extent that Circadin® is a licensed product, its use outside of licence (in so far as the tablet is broken or crushed) is considered preferable to an unlicense ...
4427 Naltrexone/Carers.NSW
... alcoholic liver disease. The doctor should be informed of any liver conditions that the patient has. • Pregnant and breastfeeding women should seek the advice of their doctor. It has not been established that using naltrexone during pregnancy is completely safe. • There are better outcomes of naltre ...
... alcoholic liver disease. The doctor should be informed of any liver conditions that the patient has. • Pregnant and breastfeeding women should seek the advice of their doctor. It has not been established that using naltrexone during pregnancy is completely safe. • There are better outcomes of naltre ...